People · Operator

Marc T. Ray

Named in public records as an officer, director or promoter · active 2010–2012 · Biotechnology, Other Health Care

2
Companies
4
Filings
$25.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
MedPro Investments LLCBiotechnologySeries B$25.0M$992.2M2010
MedPro Safety Products, Inc.Other Health CarePre-Seed$727K$22.4M2012
Operator network

Marc T. Ray at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Craig T Turner · 1 companies · 1 sharedCraig T TurnerWalter W. Weller · 1 companies · 1 sharedWalter W. WellerW. Craig Turner · 1 companies · 1 sharedW. Craig TurnerCarl A. Kleidman · 1 companies · 1 sharedCarl A. KleidmanC. Garyen Denning · 1 companies · 1 sharedC. Garyen DenningErnest L. Fletcher · 1 companies · 1 sharedErnest L. FletcherGary A. Peterson · 1 companies · 1 sharedGary A. PetersonGregory C. Schupp · 1 companies · 1 sharedGregory C. SchuppWarren A. Rustand · 1 companies · 1 sharedWarren A. RustandWilliam Craig Turner · 1 companies · 1 sharedWilliam Craig Tur…William Leo Kiely III · 1 companies · 1 sharedWilliam Leo Kiely…MedPro Investments LLC · $25.0M raisedMedPro Investments LLCMedPro Safety Products, Inc. · $0.7M raisedMedPro Safety Product…Marc T. RayMR
Marc T. Ray Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Marc T. Ray on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Gary A. Peterson11
Carl A. Kleidman11
William Leo Kiely III11
William Craig Turner11
C. Garyen Denning11
Ernest L. Fletcher11
Gregory C. Schupp11
Warren A. Rustand11
W. Craig Turner11
Walter W. Weller11
Craig T Turner11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.